Parkinson hastalığında derin beyin stimülasyonunun erken dönem sonuçları: olgu sunumu

Subtalamik çekirdek derin beyin stimülasyonu (STN-DBS) Parkinson hastalığında alternatif bir tedavi yöntemidir. Bu çalışmanın amacı Parkinson hastalığında STN-DBS'nin erken dönem sonuçları üzerine etkisini bir olgu bağlamında incelemektir. Parkinson hastalığında bir tedavi yöntemi olarak STN-DBS cerrahisi geçiren 45 yaşında erkek hasta sunuldu. Olgu ameliyat öncesi ve sonrası olmak üzere iki kez değerlendirildi. STN-DBS cerrahisinin Parkinson hastasında Parkinson Hastalığının klinik şiddetini azalttığı, hastanın belirli mesafe arasını daha kısa sürede yürüdüğü, belirli zaman aralığında hareket tekrar sayısının arttığı, anksiyete ve depresyon düzeyinin azaldığı belirlendi. Sonuç olarak STN-DBS'in Parkinson hastalığında fiziksel fonksiyonlar üzerine olumlu etkisi belirlenmiş olup, kognitif fonksiyonlardaki değişikliklerin değerlendirilebilmesi için işlem sonrası izlem çalışmasının yapılması yararlı olabilir.

Early-term results of deep brain stimulation in Parkinson's disease: a case report

Subthalamic nucleus deep brain stimulation (STN-DBS) is a alternative treatment in Parkinson's disease. The iam of this case report is to present a case with a positive effect of STN-DBS on early-term results in Parkinson's disease. A 45-year-old man who underwent STN-DBS surgery as a treatment method for Parkinson's Disease was presented. He was assessed in preoperative and postoperative period. STN-DBS surgery reduced the clinical severity of Parkinson's disease, the patient walked a certain distance in a shorter period, increased number of motion repetitions at a certain time interval, and decreased anxiety and depression level. In conclusion STN DBS surgery has a positive effect on physical functions in Parkinson's disease and it may be useful to perform follow-up study in order to evaluate changes in cognitive functions.

Keywords:

Parkinson's Disease, Subthalamic Nucleus, Physical Function Cognitive Function, Emotional Status,

PDF

___

1. De Rosa A, Tessitore A, Bilo L, Pelusu S, De Michele G. Infusion treatments and deep brain stimulation in Parkinson's Disease: The role of nursing. Geriatr Nurs. 2016;37:434-9.
2. Luoma J, Pekkonen E, Airaksinen K, Helle L, Nurminen J, Taulu S, et al. Spontaneous sensorimotor cortical activity is suppressed by deep brain stimulation in patients with advanced Parkinson's disease. Neurosci Lett. 2018;683:48-53.
3. Ulusoy EK, Ayar E, Bayındırlı D. Facial emotion recognition and discrimination deficit in idiopatic Parkinson patients. Turk J Neurol. 2015;21:16-21.
4. Koçyiğit M, Akpek E, Güllü AÜ, Şenay Ş, Alhan C. Anesthesia experiences and coronary artery bypass surgery in a patient with deep brain stimulation. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi. 2015;6:43-5.
5. Combs HL, Garcia-Willingham NE, Berry DTR, van Horne CG, Segerstrom S. Psychological functioning in Parkinson's disease post-deep brain stimulation: Self-regulation and executive functioning. J Psychosom Res. 2018;111:42-9.
6. Altuğ F, Acar F, Acar G, Cavlak U. The influence of subthalamic nucleus deep brain stimulation on physical, emotional, cognitive functions and daily living activities in patients with Parkinson’s disease. Turk Neurosurg. 2011;21:140-6.
7. Diez-Cirarda M, Ibarretxe-Bilbao N, Peria J, Ojeda N. Efficacy of cognitive rehabilitation in Parkinson's disease. Neural Regen Res. 2018;13:226-7.
8. Giorgio Rizzone M, Martone T, Balestrino R, Lopiano L. Genetic background and outcome of deep brain stimulation in Parkinson's disease. Parkinsonism Relat Disord. 2019;64:8-19.
9. Brahimaj B, Kochanski RB, Sani S. Microelectrode accuracy in deep brain stimulation surgery. J Clin Neurosci. 2018;50:58-61.
10. Halpern C, Hurtig H, Jaggi J, Grossman M, Won M, Baltuch G. Deep brain stimulation in neurologic disorders. Parkinsonism Relat Disord. 2007;13:1-16.
11. Savaş A, Akbostancı C. Surgical technique and management of Parkinson's Disease. Turkiye Klinikleri J Neurol-Special Topics. 2008;1(4):103-8.
12. Benabid AL, Pollak P, Louveau A, Henry S, de Rougemont J. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol. 1987;50:344-6.
13. Timmermann L, Jain R, Chen L, Maarouf M, Barbe MT, Allert N et al. Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson’s disease (the VANTAGE study): A nonrandomised, prospective, multicentre, open-label study. Lancet Neurol. 2015;14:693-701.
14. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P et al. Movement disorder society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. J Mov Disord. 2008;23:2129-70.
15. Akbostancı MC, Balaban H, Atbaşoğlu C. Birleşik Parkinson Hastalığı Değerleme Ölçeği Motor Muayene Bölümü ve Anormal İstemsiz Hareketler Ölçeği’nin değerlendiriciler arası güvenilirlik çalışması. Parkinson Hastalığı ve Hareket Bozuklukları Dergisi. 2000;3:7-13.
16. Hoehn MM, Yahr MD. Parkinsonizm: Onset, progression and mortality. Neurology. 1967;17:427- 42.
17. Official MDS Translation 2016 International Parkinson and Movement Disorder Society (MDS). https://www.movementdisorders.org/MDSFiles1/Education/Rating-Scales/MDSUPDRS_Turkish_OfficialTranslation_FINAL.pdf.
18. Aydemir Ö, Güvenir T, Küey L, Kültür S. Validity and reliability of Turkish Version of Hospital Anxiety and Depression Scale. Turk Psikiyatri Derg. 1997;8:280-7.
19. Öner N, Le Compte A. Durumluluk-Sürekli Kaygı Envanteri El Kitabı. 2. Baskı, İstanbul: Boğaziçi Yayınevi, 1998.
20. Hodkinson HM. Evaluation of a mental test scores for assessment of mental impairment in the elderly. Age Ageing. 1972;1:233-8.
21. Dirik A, Cavlak U, Akdag B. Identifying the relationship among mental status, functional independence and mobility level in Turkish institutionalized elderly: Gender differences. Arch Gerontol Geriatr. 2006;42:339-50.
22. Schwab RS, England AC. Projection technique for evaluating surgery in parkinson’s disease. Third Symposium on Parkinson's Disease. Edinburgh, Livingstone, 1969.
23. Balcı BD, Kara B, Colakoğlu BD, Çakmur R. Parkinson hastalarında ev programı egzersizlerinin denge ve fonksiyonel kapasite üzerine etkisi. Noro Psikiyatr Ars. 2010;47:53-7.
24. Oğuz S, Tekeoğlu A, Mutluay F, İşsever H, Kızıltan G, Özekmekçi S et al. Parkinson hastalarında üst ekstremite performansının değerlendirilmesi: Dokuz Delikli Peg Testi ile Birleştirilmiş Parkinson Hastalığı Değerlendirme Ölçeği'nin karşılaştırılması. Turk J Physiother Rehabil. 2009;20:49-55.
25. Kalenka A, Schwarz A. Anaesthesia and Parkinson’s disease: how to manage with new therapies? Curr Opin Anaesthesiol. 2009;22:419-24.
26. Holslag JAH, Neef N, Beudel M, Drost G, Oterdoom DLM, Kremer NI et al. Deep brain stimulation for essential tremor: A comparison of Targets. World Neurosurg. 2018;110:580-4.
27. Savaş A, Akbostancı C, Kanpolat Y. Surgical Treatment of Parkinson's Disease. Turkiye Klinikleri J Neurosurg-Special Topics. 2008;1:5-12.
28. Tabbal SD, Ushe M, Mink CW, Revilla F, Wernle AR, Hong M et al. Unilateral subthalamic nucleus stimulation has a measurable ipsilateral effect on rigidity and bradykinesia in Parkinson Disease. Exp Neurol. 2008;211:234-42.
29. Slowınskı JL, Putzke JD, Uıttı RJ, Lucas JA, Turk MF, Kall BA, et al. Unilateral deep brain stimulation of the subthalamic nucleus for Parkinson Disease. J Neurosurg. 2007;106:626-32.
30. Llumiguano C, Kosztolany P, Kovacs N, Doczi T, Balas I. Bilateral STN DBS improves manual performance time in Parkinson's Disease. J Mov Disord. 2008;23:114-14.
31. Moro E, Lozano AM, Pollak P, Agid Y, Rehncrona S, Volkmann J et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson’s Disease. J Mov Disord. 2010;25:578-86.
32. Zhang JG, Zhang K, Ma Y, Hu H, Yang AC, Chu JS, et al. Follow-up of bilateral subthalamic deep brain stimulation for Parkinson's Disease. Acta Neurochir Supp. 2006;99:43-7.
33. Nilsson MH, Fransson PA, Jarnlo GB, Magnusson M, Rehncrona S. Research the effects of high frequency subthalamic stimulation on balance performance and fear of falling in patients with Parkinson's Disease. J Neuroeng Rehabil. 2009;6:1- 10.
34. Lubik S, Fogel W, Tronnier V, Krause M, König J, Jost WH. Gait analysis in patients with advanced Parkinson Disease: Different or additive effects on gait induced by levodopa and chronic STN stimulation. J Neural Transm. 2006;113:163-73.
35. Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med. 2010;362:2077-91.
36. Kelly VE, Israel SM, Samii A, Slimp JC, Goodkin R, Shumway-Cook A. Assessing the effects of subthalamic nucleus stimulation on gait and mobility in people with Parkinson Disease. Disabil Rehabil. 2010;32:929-36.
37. Yılmaz R, Akbostancı MC, Mercan FN, Sorgun MH, Savaş A. No effect of different stimulation conditions on verbal fluency and visuospatial orientation in patients with subthalamic nucleus deep brain stimulation. Stereotac Funct Neurosurg. 2015;93:326-32.
38. Apaydın H, Emre M. Parkinson hastalığında demans ve tedavisi. Türkiye Klinikleri J Neur. 2003;1:206-12.
39. Fraix V, Houeto JL, Lagrange C, Le Pen C, Krystkowiak P, Guehl D et al. Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2006;77:443-9.
40. Witt K, Daniels C, Reiff J, Krack P, Volkmann J, Pinsker MO et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson’s disease: A randomized, multicentre study. Lancet Neurol. 2008;7:605-14.
41. Zangaglia R, Pacchetti C, Pasotti C, Mancini F, Servello D, Sinforiani E et al. Deep brain stimulation and cognitive functions in Parkinson's disease: A three-year controlled study. J Mov Disord. 2009;24:1621-8.
42. Funkiewiez A, Ardouin C, Caputo E, Krack P, Fraix V, Klinger H et al. Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson’s Disease. J Neurol Neurosurg Psychiatry. 2004;75:834-9.
43. Appleby B, Duggan P, Regenberg A, Rabins PV. Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: A metaanalysis of ten years experience. J Mov Disord. 2007;22:1722-8.
44. Reijnders JS, Ehrt U, Weber WE, Aarsland D, Leentjens AF. A systematic review of prevalence studies of depression in Parkinson's disease. J Mov Disord. 2008;23:183-9.
45. Bhattacharjee S, Vadiei N, Goldstone L, Alrabiah Z, Sherman SJ. Patterns and predictors of depression treatment among older adults with Parkinson's Disease and depression in ambulatory care settings in the United States. Parkinsons Dis. 2018;2018:3402983.
46. Martínez-Martín P, Valldeoriola F, Tolosa E, Pilleri M, Molinuevo JL, Rumia J et al. Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson's Disease. J Mov Disord. 2002;17:372-7.
47. Wang X, Chang C, Geng N, Li N, Wang J, Ma J et al. Long-term effects of bilateral deep brain stimulation of the subthalamic nucleus on depression in patients with Parkinsons disease. Parkinsonism Relat Disord. 2009;15:587-91.
48. Nomm S, Toomela A, Vaske M, Uvarov D, Taba P. An alternative approach to distinguish movements of Parkinson disease patients. IFAC-PapersOnLine. 2016;49:272-6.
49. Onur E, Yemez B, Cengizçetin N, Mertol S, Yaka E, Gürzyalçın N et al. Factors affecting on depression and quality of life patients with Parkinson's disease. Noro Psikiyatr Ars. 2007;44:49-53.
50. Brozova H, Barnaure I, Alterman RL, Tagliati M. STN-DBS frequency effects on freezing of gait in advanced Parkinson Disease. Neurology. 2009;72:770-1.
51. Yamada K, Hamasaki T, Kuratsu Jİ. Subthalamic nucleus stimulation applied in the earlier vs. advanced stage of Parkinson’s Disease-retrospective evaluation of postoperative independence in pursuing daily activities. Parkinsonism Relat Disord. 2009;15:746-51.
52. Powell DW, Blackmore SE, Puppa M, Lester D, Murray NG, Reed-Jones RJ et al. Deep brain stimulation enhances movement complexity during gait in individuals with Parkinson's disease. Neurosci Lett. 2018; doi:10.1016/j.neulet.2018.05.010.